What does Somnigroup do and what are its main business segments?

Did Somnigroup beat or miss consensus estimates last quarter?

What factors drove the changes in Somnigroup's revenue and profit?

What is Somnigroup's gross profit margin?

What is the revenue and EPS growth rate for Somnigroup year over year?

What is the market's earnings forecast for Somnigroup next quarter?

What were the key takeaways from Somnigroup's earnings call?

What guidance did Somnigroup's management provide for the next earnings period?

- **Record Growth**: Q3 2025 net sales up 63% YoY to $2.1B, EBITDA +52% to $419M, EPS +16% to $0.95. 
- **Market Leadership**: 5% like-for-like sales growth vs. flat U.S. market, Tempur-Chili share at Mattress Firm now mid-50%. 
- **Investment Payoff**: $110M Q3 ad spend drives brand momentum, Kingsdown partnership adds luxury segment exposure. 
- **Financial Strength**: $360M free cash flow, debt down $300M QoQ, targeting 2-3x leverage for 2026 shareholder returns. 
- **Interest Rate Leverage**: 100bp rate decline could add $0.18-$0.20 to EPS, 7%+ boost to 2025 EPS midpoint.

**【CEO Summary Section】**
- **Record Financial Performance**: Q3 2025 net sales reached $2.1 billion (+63% YoY), adjusted EBITDA of $419 million (+52% YoY), and adjusted EPS of $0.95 (+16% YoY). 
- **Market Outperformance**: Like-for-like sales growth of 5% driven by North America (+5% QoQ, strongest in 9 quarters) and international (+11% YoY). 
- **Strategic Investments**: 
  - $110M in Q3 advertising (highest in brand history) for Tempur-Pedic and Chili. 
  - $150M 3-year store refresh program for Mattress Firm (2,200 locations by end-2026). 
  - 25% equity stake in Kingsdown for luxury mattress expansion. 
- **Synergy Progress**: Tempur-Chili share at Mattress Firm now mid-50% (vs. low-50% prior), with $60M EBITDA benefit in 2025 and $40M in 2026. 
- **Long-Term Vision**: Targeting $100M+ annual run-rate synergies by 2027, with potential for unquantified ad efficiency gains. 

**【CFO Financial Commentary】**
- **Balance Sheet Strength**: Debt reduced by $300M QoQ to $4.6B, leverage ratio down to 3.3x (target 2-3x). 
- **Cash Flow Excellence**: Record Q3 free cash flow of $360M, with plans to return 50% of free cash flow to shareholders starting Q1 2026. 
- **Guidance Update**: 2025 EPS raised to $2.60-$2.75 (midpoint +16%), driven by: 
  - North America: 10% wholesale growth, 4% direct channel decline. 
  - International: 11% reported sales growth, 7% constant currency. 
  - Gross margin >44%, capex $150M (normal) + $25M for store upgrades. 
- **Tariff Mitigation**: $20M incremental cost offset by small 2026 price increase. 

**【Q&A Highlights】**
- **Demand Drivers**: Innovation (Sealy Posturepedic, Chili Posturepedic) and advertising outperforming industry (-low/mid-single digits). 
- **Growth Opportunities**: 
  - Sealy Posturepedic leading North America, Tempur International on track for 10+ years of double-digit growth. 
  - Kingsdown to expand in luxury segment with 25% passive stake. 
- **Interest Rate Impact**: 100bp rate decline could add $0.18-$0.20 to EPS (7%+ boost). 
- **2026 Outlook**: Targeting 2-3x leverage, with capital returns tied to deleveraging progress.

Somnigroup International Inc(SGI)-20251106-2025 Q3 Earnings call transcript

- **Q2 Growth Milestones**: $1.9B revenue (+53% YoY), $291M EBITDA (+26% YoY), $0.53 EPS. North America outperformed industry by 600-700 basis points.
- **Synergy Payoff**: $40M EBITDA benefit from Tempur share shift at Mattress Firm, with $100M+ by 2026. $20M marketing efficiencies identified.
- **Sealy Innovation Success**: Largest launch in industry history, doubling share of voice and driving AOV growth.
- **Balance Sheet Strength**: $4.9B debt, 3.6x leverage, with 2025 EPS guidance raised to $2.40-$2.70.
- **Tariff Mitigation**: 2% price increase offsetting tariffs, with minimal consumer impact.

**【CEO Summary Section】**
- **Record Q2 Performance**: Net sales reached $1.9 billion (+53% YoY), with adjusted EBITDA of $291 million (+26% YoY). Adjusted EPS was $0.53.
- **North American Market Outperformance**: Mattress Firm reported like-for-like sales down 1% vs. industry decline of high single digits. Tempur Sealy North America sales were down 2% (excluding distribution headwinds), outperforming the market.
- **Merchandising Synergies**: Tempur Sealy's share of Mattress Firm sales rose to low 50% (from high 40%), driving $40 million EBITDA benefit in 2025 and $100 million by 2026.
- **Sealy Posturepedic Launch Success**: Largest bedding launch in history, with 4.9/5 consumer ratings and strong retailer feedback. Advertising campaign doubled Sealy's share of voice.
- **International Growth**: International sales grew 15% (10% constant currency), with Tempur products driving expansion and Dreams UK outperforming the market.
- **Innovation Investment**: $25 million equity stake in Fullpower for Sleeptracker-AI technology, with exclusive rights through 2036.

**【CFO Financial Commentary】**
- **Financial Highlights**: GAAP net sales $1.9 billion, adjusted EBITDA $291 million. North America adjusted gross margin 55% (vs. 43.5% prior year), driven by intercompany sales elimination.
- **Synergy Progress**: $15 million cost synergies realized in 2025, with $50 million expected in 2026 and $35 million in 2027. Marketing efficiencies of $20 million identified.
- **Balance Sheet**: Debt less cash $4.9 billion, leverage ratio 3.6x. 2025 guidance updated to $2.40-$2.70 EPS, with $1.27 billion EBITDA midpoint.
- **Tariff Mitigation**: 2% price increase implemented to offset tariffs, with minimal pass-through to consumers.

**【Q&A Key Highlights】**
- **Demand Trends**: Q2 started soft but improved, with early Q3 trends encouraging. Consumer confidence stabilization and product innovation (Sealy Posturepedic) drove recovery.
- **Revenue Synergies**: 30-35% EBITDA margin on incremental sales, with flow-through from Tempur and Sealy brands. Mix shift to Sealy may pressure gross margin temporarily.
- **Retailer Relationships**: Slot count with top 5 retailers increased, with Sealy outperforming market share. No significant cannibalization between Tempur and Sealy lines.
- **Long-Term Outlook**: 3-year $4.85 EPS target may be revised, with revenue synergies offsetting industry headwinds. Innovation pipeline (e.g., Fullpower) positions for future growth.

Somnigroup International Inc. (SGI) Q2 2025 Earnings Call Transcript

- **International Expansion Success**: International sales grew 8% (constant currency), with Tempur Collection driving 10% distribution gains.
- **North America Resilience**: North American sales down 3% (adjusted), outperforming the industry's mid-single-digit decline. Sealy Posturepedic launch on track for Memorial Day flooring.
- **Tariff Mitigation**: $120 million tariff impact reduced to $60 million via supplier collaboration and 2% price increase. Q2 faces $5 million one-time tariff headwind.
- **Synergy Acceleration**: 2025 cost synergies increased to $15 million, leveraging advertising scale and logistics efficiency.
- **Q2 Outlook**: EPS expected at $0.50, with improving demand trends and Sealy launch momentum.


**【CEO Summary Section】**
- **International Growth**: International sales grew 8% on a constant currency basis, driven by the Tempur Collection expansion and Dreams' mid-single-digit growth. The Tempur Collection achieved over 10% distribution growth with third-party retailers.
- **North America Outperformance**: Tempur Sealy North America sales declined 3% (excluding foreclosed distribution), while Mattress Firm sales fell 1%, both outpacing the broader U.S. bedding market (estimated down mid-single digits). The Sealy Posturepedic launch is 80% floored by Memorial Day, with early results showing share gains.
- **Tariff Mitigation**: $120 million annual tariff impact reduced to $60 million through supplier collaboration and 2% price increase effective Q3. A one-time $5 million tariff headwind is expected in Q2.
- **Synergy Progress**: $15 million 2025 cost synergies (up from $10 million) achieved through logistics streamlining, advertising scale, and merchandising optimization. Combined advertising spend is now the industry's largest by a factor of 2.

**【CFO Financial Commentary】**
- **Q1 2025 Results**: Adjusted EPS of $0.49 on $1.6 billion net sales. North American gross margin improved 760 basis points to 45.3% due to intercompany sales elimination. International gross margin rose 130 basis points to 49%.
- **Full Year Guidance**: Adjusted EPS revised to $2.30-$2.65 (down from prior $2.50-$2.80) due to weaker consumer confidence. Sales expected to be $7.3-$7.5 billion, with gross margins slightly above 44%. Capital expenditures of $225 million include $25 million for Mattress Firm store refreshes.
- **Balance Sheet**: Debt less cash of $5 billion, leverage ratio of 3.5x. Free cash flow of $106 million in Q1.

**【Q&A Highlights】**
- **Demand Trends**: Q2 EPS expected at $0.50 (down 20% YoY), with choppy demand but improving momentum post-President's Day. Sealy launch and price increases are key second-half drivers.
- **Tariff Impact**: 50% of tariff impact mitigated through supply chain adjustments. Mattress Firm expects to pass through supplier price increases without material headwinds.
- **Mattress Firm Leverage**: Incremental sales at Mattress Firm have a 30%-40% flow-through rate. Divested stores will reduce 2025 sales by ~$100 million, with minimal profit impact.
- **Brand Performance**: Tempur outperformed Sealy in the U.S., while international Tempur growth offset entry-level product softness.


Somnigroup International Inc. (SGI) Q1 2025 Earnings Call Transcript

- **Q4 2024 Strong Finish**: Adjusted EPS $0.60, revenue $1.2B, outperforming expectations with international growth and stable North America sales.
- **Sealy Launch Catalyst**: 2025 Posturepedic collection driving bedding industry recovery, supported by $730M in advertising investments.
- **Long-Term Growth Ambition**: 20% EPS CAGR to $4.85 by 2028, fueled by $100M annual synergies from Mattress Firm acquisition.
- **Financial Discipline**: Free cash flow $569M, debt deleveraging to 2.3x, with minimal share buybacks in 2025.
- **Risk Management**: Tariff impacts manageable through supplier flexibility, while maintaining focus on operational efficiency and innovation.


**【CEO Summary Section】**
- **Q4 2024 Performance**: Revenue of $1.2B, adjusted EPS of $0.60, outperforming expectations driven by international growth. North America sales remained stable despite industry decline, with low-single-digit growth excluding foreclosed distribution impacts.
- **Product Innovation**: Launch of Sealy Posturepedic 2025 collection, the largest product launch in bedding history, supported by a national ad campaign. Tempur brand growth driven by Breeze and Smart Base products, Stearns & Foster e-commerce up 20%.
- **Long-Term Outlook**: Targeting mid-single-digit sales CAGR starting 2026, with adjusted EPS growing at 20% CAGR to $4.85 by 2028. Synergies from Mattress Firm acquisition expected to reach $100M annually by 2028.

**【CFO Financial Commentary】**
- **Q4 2024 Financials**: GAAP net income $420M, Non-GAAP EPS $1.08 (vs. $0.60 prior). Gross margin improved 130bps to 40.8%, driven by operational efficiencies and product mix. Free cash flow $569M, debt-to-EBITDA ratio reduced to 2.3x.
- **2025 Guidance**: Adjusted EPS $2.60-$3.00 (10% growth midpoint). Sales $7.5B-$7.8B, with North America flat on like-for-like basis, international low-single-digit growth. Gross margin stable, advertising spend $730M.
- **Balance Sheet**: Post-Mattress Firm transaction, leverage 3.5x, targeting 2.0-3.0x by 2026. Capital expenditures $250M, including $50M for Mattress Firm store refreshes.

**【Q&A Highlights】**
- **Industry Recovery**: Expect stabilization in 2025, with growth resuming in H2. Sealy launch and product innovation key to outperforming industry decline.
- **Synergies**: $10M in 2025, ramping to $100M annually by 2028. Advertising consolidation and operational efficiencies driving cost savings.
- **Tariff Impact**: Potential headwinds from tariffs, but flexibility in supplier relationships and production locations to mitigate costs.
- **Same-Store Sales**: Mattress Firm same-store sales growth dependent on market trends, with focus on average order value and conversion.


SGI

SGI fundamentals

Earnings Call

You can ask Aime